Detalles de la búsqueda
1.
Secondary central nervous system involvement in patients with diffuse large B-cell lymphoma treated with rituximab combined CHOP therapy - a supplementary analysis of JCOG0601.
Ann Hematol;
103(6): 2021-2031, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280061
2.
Prognostic evaluation of the Ki-67 labeling system in histological grading of non-small round cell sarcoma: a supplementary analysis of a randomized controlled trial, JCOG1306.
Jpn J Clin Oncol;
2024 Feb 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38391203
3.
A phase III randomized controlled trial comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer: ARMADILLO trial (JCOG1904).
Jpn J Clin Oncol;
54(1): 103-107, 2024 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37801434
4.
Novel approach of prophylactic radiation to reduce toxicities comparing 2-step40 with 56-Gy simultaneous integrated boost intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the head and neck, an intergroup phase III trial (JCOG1912, NEW BRIDGE).
BMC Cancer;
23(1): 1068, 2023 Nov 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932681
5.
Protocol for the 2ND-STEP study, Japan Clinical Oncology Group study JCOG1802: a randomized phase II trial of second-line treatment for advanced soft tissue sarcoma comparing trabectedin, eribulin and pazopanib.
BMC Cancer;
23(1): 219, 2023 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36890471
6.
Clinical trial design and analysis for comparing three treatments with intra-individual right- and left-hand data.
Clin Trials;
20(3): 203-210, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36651336
7.
Perioperative Adriamycin plus ifosfamide vs. gemcitabine plus docetaxel for high-risk soft tissue sarcomas: randomised, phase II/III study JCOG1306.
Br J Cancer;
127(8): 1487-1496, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35871234
8.
A multicenter investigator-initiated Phase 2 trial of E7090 in patients with advanced or recurrent solid tumor with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.
BMC Cancer;
22(1): 869, 2022 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35945547
9.
Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.
Jpn J Clin Oncol;
52(6): 583-588, 2022 May 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-35353186
10.
A randomized phase III trial of denosumab before curettage for giant cell tumor of bone. JCOG1610.
Jpn J Clin Oncol;
52(9): 1021-1028, 2022 Sep 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-35472141
11.
Topical corticosteroid therapy for facial acneiform eruption due to EGFR inhibitors in metastatic colorectal cancer patients: a randomized controlled trial comparing starting with a very strong or a weak topical corticosteroid (FAEISS study, NCCH1512, colorectal part).
Support Care Cancer;
30(5): 4497-4504, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-35113224
12.
Long-term survival of patients with T1bN0M0 esophageal cancer after thoracoscopic esophagectomy using data from JCOG0502: a prospective multicenter trial.
Surg Endosc;
36(6): 4275-4282, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34698936
13.
TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma.
Acta Neuropathol;
142(2): 323-338, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34148105
14.
Predicting study duration in clinical trials with a time-to-event endpoint.
Stat Med;
40(10): 2413-2421, 2021 05 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33580519
15.
Impact of postoperative complications on survival outcomes in patients with gastric cancer: exploratory analysis of a randomized controlled JCOG1001 trial.
Gastric Cancer;
24(1): 214-223, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32601909
16.
Final analysis of a Multicenter Single-Arm Confirmatory Trial of hypofractionated whole breast irradiation after breast-conserving surgery in Japan: JCOG0906.
Jpn J Clin Oncol;
51(6): 865-872, 2021 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33728450
17.
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Jpn J Clin Oncol;
51(7): 1059-1066, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959770
18.
Lenvatinib in patients with advanced or metastatic thymic carcinoma (REMORA): a multicentre, phase 2 trial.
Lancet Oncol;
21(6): 843-850, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32502444
19.
Randomized controlled Phase III trial to evaluate omentum preserving gastrectomy for patients with advanced gastric cancer (JCOG1711, ROAD-GC).
Jpn J Clin Oncol;
50(11): 1321-1324, 2020 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32638017
20.
The association of primary tumor site with acute adverse event and efficacy of definitive chemoradiotherapy for cStage II/III esophageal cancer: an exploratory analysis of JCOG0909.
Esophagus;
17(4): 417-424, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32342253